Part 3: ApiJect committed to creating emergency temporary fill-finish capacity for up to 45M doses a month of a candidate COVID-19 vaccine on BFS lines by the end of 2020. All of these BFS-packaged doses could then be used, if necessary, in ApiJect Prefilled Injectors for scalable, single-dose delivery.
August 25, 2021
Single-Dose Drug Delivery Fill-Finish Facility ... within an Accelerated Timeline of Fewer Than 7 Months
Might interest you
View All
Global Health
Affordable Prefilled Devices Greatly Expand Access
At Apiject, we believe a higher level of universal expanded access can be achieved by providing injectable medicine and vaccines in single-use, prefilled injectors that are simple, affordable, and can overcome many “Last Mile” challenges.
Global Health
Delivering Every Dose Better: Frontline Interviews
These frontline interviews and user testing sessions are invaluable sources of feedback that allow our engineers to design and manufacture modifications to better serve these constituencies’ needs
Global Health
ApiJect Systems Receives Grant to Develop Low-Cost Blow-Fill-Seal Prefilled Injection Device for Low- and Middle-Income Countries
Grant will fund the design and development of an affordable, multi-month contraceptive delivery device to enhance access in Low- and Middle-Income Countries (LMICs). Blow-Fill-Seal will be explored for the container closure and subcutaneous injection delivery system, advancing a concept initially developed by...